Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 28, 2015, to report its financial results for the quarter ended June 30, 2015. The report primarily serves to attach a press release detailing these results, which were presented on both a GAAP and non-GAAP basis. Management believes the non-GAAP presentation offers additional utility for investors by providing insights into internal operating, budgeting, and financial planning metrics. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for comprehensive information, including a reconciliation between GAAP and non-GAAP figures. Investors should note that this information is furnished, not filed, and therefore not subject to the liabilities of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings.
Key Highlights
- 1Gilead Sciences announced its Q2 2015 financial results via an 8-K filing on July 28, 2015.
- 2The filing incorporates a press release (Exhibit 99.1) containing the detailed financial results.
- 3Financial results were provided on both a GAAP and non-GAAP basis.
- 4Management highlights the usefulness of non-GAAP measures for understanding operating, budgeting, and financial planning.
- 5A reconciliation between GAAP and non-GAAP financial information is available in the press release.
- 6The information furnished in this 8-K is not considered 'filed' for Section 18 purposes and is not automatically incorporated into other SEC filings.